Advances in Differentiated Service Delivery (DSD) and antiretroviral drug optimization in Zimbabwe have made HIV care and treatment more acceptable and effective, leading to greater coverage and better health outcomes—especially for patients with advanced or unstable HIV.

With an in-depth understanding of the status of the national HIV epidemic through the Zimbabwe Population-based HIV Impact Assessment (ZIMPHIA) surveys conducted in 2016 and 2020, ICAP has continued working to improve service quality, strengthen human resources for health, and build capacity in epidemiology and strategic information (SI) for evidence-based HIV programs, policy and response.



Accelerating Availability of Optimal Antiretroviral Drugs (OPTIMIZE)

COVID -19 Response (supplemental funding)Districts (or national):National

CQUIN Project for Differentiated Service Delivery

Evaluating Differentated Service Delivery Preferences

Population-based HIV Impact Assessment (PHIA)Districts (or national):National

Strengthening Epidemiology and Strategic Information (SI) in the Republic of ZimbabweDistricts (or national):National

Tracking with Recency Assays to Control the Epidemic (TRACE)

Zimbabwe 3HP Rollout in Fast Track ModelDistricts (or national):Harare


HIV and STI Biobehavioral Survey among Men Who Have Sex with Men, Transgender Women, and Genderqueer Individuals in Zimbabwe Districts (or national):Harare,Bulawayo

Leveraging Community Antiretroviral Groups (CARGs) to Delivery Tuberculosis Preventive Therapy (TPT) in ZimbabweDistricts (or national):Harare,Guruve,Mhondoro-Ngezi

Male Engagement in Community Antiretroviral Refill Groups (CARGs) in Zimbabwe: Exploring Barriers and Facilitators to Differentiated CareDistricts (or national):Guruve,Mhondoro-Ngezi

Optimizing Differentiated Service Delivery for People Living with HIV (PLHIV) in Urban Zimbabwe: Assessing urban PLHIV preferences for treatment delivery models using a discrete choice experimentDistricts (or national):Harare

Optimizing Momentum Toward Sustainable Epidemic Control (OpCon): DSD for HIVDistricts (or national):Harare

Optimizing Momentum Toward Sustainable Epidemic Control (OpCon): Preventing TB through CARGsDistricts (or national):Harare,Guruve,Mhondoro-Ngezi

ICAP in Zimbabwe

Program Start
  • 2015
Key Technical Areas
  • Capacity Building of Health Workforce
  • DREAMS (Women’s HIV Prevention)
  • Health Information Systems
  • Key / Priority Populations
  • Implementation Science / Operations Research
  • Laboratory Support
  • Monitoring & Evaluation / SI
  • Recency Testing
  • Surveillance
  • Treatment Optimization  
  • Tuberculosis
Current Funders
  • Bill & Melinda Gates Foundation

  • U.S. President’s Emergency Program for AIDS Relief (PEPFAR) / Centers for Disease Control and Prevention (CDC)

  • PEPFAR / Health Resources & Services Administration (HRSA)

  • Wits Reproductive Health Initiative

Country Director

Tafadzwa Dzinamarira, MSc, MPH, PhD

Tafadzwa Dzinamarira, MSc, MPH, PhD, is ICAP’s interim country director in Zimbabwe. He is a public health expert with a strong background in clinical and epidemiological research, and more than seven years of experience providing technical support for public health systems and clinical laboratories strengthening the management of HIV/AIDS programs. Dr. Dzinamarira has expertise in providing technical leadership in the design, development, planning, and implementation, of national household-based biomarker surveys. Tafadzwa holds a Master of Science in HIV/AIDS Management, a Master of Public Health (Disease Prevention and Control), and a Doctor of Philosophy in Public Health Medicine. Prior to this role, Dr. Dzinamarira was the Regional Laboratory Technical Advisor for the PHIA project where he successfully supported the implementation of national HIV impact assessment surveys in Namibia, Rwanda, Haiti, Eswatini, Lesotho, Malawi, Mozambique, Uganda, Tanzania, and Zimbabwe. Prior to joining ICAP, Tafadzwa worked for the University of Zimbabwe Department of Medicine on a series of prospective operation research aimed at decreasing mortality associated with initiation of antiretroviral therapy in Sub-Saharan Africa through early detection and prevention of cryptococcal disease in Zimbabwe. Prior to joining the University of Zimbabwe, Tafadzwa worked for UCSF on a study that investigated HIV-target cell response in women initiating various contraceptive methods in high HIV-incidence areas.

Jobs in Zimbabwe

For international ICAP job listings see careers at ICAPACITY